Long-term therapy of chronic hepatitis B with lamivudine.
about
Entecavir for chronic hepatitis BEntecavir for chronic hepatitis BHigh rates of early HBeAg seroconversion and relapse in Indian patients of chronic hepatitis B treated with Lamivudine: results of an open labeled trial.Liver transplantation for viral hepatitis in 2015Clinical utility of entecavir for chronic hepatitis B in Chinese patientsViral quasispecies evolutionDirect acting antivirals for the treatment of chronic viral hepatitisCombination of small interfering RNAs mediates greater suppression on hepatitis B virus cccDNA in HepG2.2.15 cellsRecent advances in micro/nanotechnologies for global control of hepatitis B infectionDetection of YMDD motif mutants by oligonucleotide chips in lamivudine-untreated patients with chronic hepatitis B virus infection.Evaluation of transcriptional efficiency of hepatitis B virus covalently closed circular DNA by reverse transcription-PCR combined with the restriction enzyme digestion methodNovel approaches towards conquering hepatitis B virus infection.Clinical efficacy of a 24-months course of lamivudine therapy in patients with HBeAg negative chronic hepatitis B: a long-term prospective study.Antiviral effect of oral administration of tenofovir disoproxil fumarate in woodchucks with chronic woodchuck hepatitis virus infection.Long-term effect of interferon plus ribavirin on hepatitis B surface antigen seroclearance in patients dually infected with hepatitis B and C viruses.Management of viral hepatitis B.Clinical significance of hepatitis B e antigen level measurement during long-term lamivudine therapy in chronic hepatitis B patients with e antigen positive.Efficacy of thymosin alpha-1 and interferon alpha in treatment of chronic viral hepatitis B: a randomized controlled studyDose range study of pharmacokinetics, safety, and preliminary antiviral activity of emtricitabine in adults with hepatitis B virus infection.Genomic analysis of anti-hepatitis B virus (HBV) activity by small interfering RNA and lamivudine in stable HBV-producing cells.Viral blips during long-term treatment with standard or double dose lamivudine in HBe antigen negative chronic hepatitis BMutations of the woodchuck hepatitis virus polymerase gene that confer resistance to lamivudine and 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil.Diagnosis and management of pre-core mutant chronic hepatitis B.Current status of antiviral therapy for hepatitis BEvolving therapies for the treatment of chronic hepatitis B virus infection.A one-year trial of entecavir treatment in patients with HBeAg-positive chronic hepatitis B.Chronic hepatitis B: current and future treatment options.Differences of YMDD mutational patterns, precore/core promoter mutations, serum HBV DNA levels in lamivudine-resistant hepatitis B genotypes B and C.Nucleoside analogues for chronic hepatitis B: antiviral efficacy and viral resistance.Probing rate of YMDD motif mutant in lamivudine treatment of Iranian patients with chronic hepatitis B virus infection.Antiviral treatment of patients with HBV-related cirrhosis.Effect of lamivudine in HBeAg-positive chronic hepatitis B: discordant effect on HBeAg and HBV DNA according to pretreatment ALT levelPrevention of and treatment for hepatitis B virus infection after liver transplantation in the nucleoside analogues era.HBV lamivudine resistance among hepatitis B and HIV coinfected patients starting lamivudine, stavudine and nevirapine in Kenya.Backs against the wall: novel and existing strategies used during the 2014-2015 Ebola virus outbreakReview article: current management of chronic hepatitis B.Prophylactic Effect of Lamivudine for Chemotherapy-Induced Hepatitis B Reactivation in Breast Cancer: A Meta-AnalysisAdefovir dipivoxil in the treatment of chronic hepatitis B.Residual integrated viral DNA after hepadnavirus clearance by nucleoside analog therapy.Characterization of resistance to the nonnucleoside NS5B inhibitor filibuvir in hepatitis C virus-infected patients.
P2860
Q24195119-CACA2130-C8B3-45C9-9156-5E6201EE36AAQ24244842-1D2C19BD-E468-406B-8FCA-7504BE873631Q24814210-4AD3EE4F-4F3B-4E80-BE57-1D8A0F9C87E7Q26773224-BF1CC70C-169B-4F62-9719-303591149440Q26830371-38F6D187-A8B2-4062-B83D-BA7D66F5039FQ27013917-1233ABD0-ECBC-4C84-8940-E9147F995FCAQ27022216-A9CCB168-70B5-49C8-A140-E69AF8303C9DQ27489094-3F678D13-42F7-4F9D-8DDF-027DBC977424Q30394611-A3B2A4BE-F719-4535-B3E2-4DD1C1F85B3AQ33631739-A35E126B-0CCE-4EA7-ADFA-57B07452A100Q33716406-43BF41DB-6FA6-46E1-B016-5A015554FC92Q33787687-480FC7C9-185B-44B9-9BF1-5535BE1B8792Q33879651-DBF2C9CC-B4B8-4EB8-9AA3-AE305048226FQ33883722-2180B826-E2EF-41D5-9DB8-689434BC8AACQ33939443-2BEC1BDA-B79C-4144-83F0-7EC3C0B64B79Q33959006-F150C3CA-BAFE-40CD-9863-E8F8E92A37D0Q34017787-FDD00DA0-D3AC-4734-A366-A3407E89DE90Q34017814-849920B0-6F18-4DEA-BAC3-9E40A10681DDQ34109170-928FD787-D18C-4AD5-9D68-9649C09743FBQ34123971-2ED221EC-684E-4932-B4E4-A35D7E93B9E6Q34233156-72D582D1-9464-4ABF-89B9-582F142705E0Q34330228-B481F49B-42B5-49BC-B1A7-1CED61808F68Q34368364-25B06007-066D-485B-98F2-ABA919A4582DQ34408879-62AEF733-B34C-4D4B-BA18-49D722EF8C6CQ34519117-9DCAFB12-75EB-4C2C-B966-ACE19C095F50Q34604857-142DF168-9258-4297-80F3-40E6C20C508BQ34687438-F185FDBA-FEAA-4EB2-AD23-B2FDDC5BD6BCQ34700034-3CA1B518-B6CE-4B67-9874-E043A5631D13Q34756218-8BC45780-B622-4A43-8F4E-11F06CC7DE13Q34862728-F67EAC62-E623-425F-B8FE-52B39A98C910Q35020817-853EEDEB-620B-456A-8F32-F248D1498DB6Q35045329-CB87A912-C7CA-4AC4-893B-A0E42B8362D1Q35076630-BEDFAFE8-C579-4190-B4C3-2931BE5C17ECQ35224111-49D7D12D-EB7E-45F0-BCB2-746CB95BC0E4Q35598919-24EC9B22-A0DC-4A93-A24E-A188125A6B30Q35612108-FA6F99A9-AEB8-4DAB-8D18-F7DA2D460D32Q35658261-A609DF24-05AC-44D0-8688-CA6B55E7B015Q35678267-6977D1F8-76BA-4374-B6D8-D8D23615574FQ35735964-395DD4EA-EF9E-4A5C-9DD6-699A1CF53514Q35806182-791082DE-75CE-470B-9519-23075811AF15
P2860
Long-term therapy of chronic hepatitis B with lamivudine.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Long-term therapy of chronic hepatitis B with lamivudine.
@en
Long-term therapy of chronic hepatitis B with lamivudine.
@nl
type
label
Long-term therapy of chronic hepatitis B with lamivudine.
@en
Long-term therapy of chronic hepatitis B with lamivudine.
@nl
prefLabel
Long-term therapy of chronic hepatitis B with lamivudine.
@en
Long-term therapy of chronic hepatitis B with lamivudine.
@nl
P2093
P356
P1433
P1476
Long-term therapy of chronic hepatitis B with lamivudine.
@en
P2093
Condreay LD
Gauthier J
Hoofnagle JH
Khokhar MF
Kleiner DE
P304
P356
10.1053/JHEP.2000.17912
P407
P433
P577
2000-10-01T00:00:00Z